New Delhi: The World Health Organization (WHO) has reportedly recommended Bharat Biotech’s Covaxin for Emergency Use Listing (EUL) on Wednesday.
According to media reports, the technical advisory team of WHO has recommended Covaxin for emergency use listing for 18 years and above, marking a major victory for India’s journey in vaccination against Covid-19.
Covaxin is a COVID vaccine prepared by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.
It is to be noted here that WHO’s approval for Covaxin to be used as emergency listing got delayed last month as the technical advisory group sought some additional clarification from Bharat Biotech for its final risk assessment.
“Covaxin vaccine was also reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above,” said WHO as quoted by news agency ANI.
“Available data on vaccination of pregnant women with the Covaxin are insufficient to assess vaccine safety or efficacy in pregnancy; studies in pregnant women are planned, including a pregnancy sub-study and a pregnancy registry,” it added.
Ms Kalinga